RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,277 | -31.0% | 124,331 | -17.6% | 0.00% | -100.0% |
| Q2 2023 | $194,547 | -68.9% | 150,812 | -68.1% | 0.00% | -66.7% |
| Q1 2023 | $624,843 | -8.1% | 473,366 | -17.9% | 0.00% | -25.0% |
| Q3 2022 | $680,000 | +103.0% | 576,606 | +414.8% | 0.00% | +33.3% |
| Q1 2022 | $335,000 | +23.2% | 112,005 | +8.9% | 0.00% | +50.0% |
| Q4 2021 | $272,000 | -32.8% | 102,816 | -7.7% | 0.00% | -60.0% |
| Q3 2021 | $405,000 | +382.1% | 111,449 | +475.3% | 0.01% | +400.0% |
| Q2 2021 | $84,000 | -73.1% | 19,373 | -78.8% | 0.00% | -80.0% |
| Q1 2021 | $312,000 | +115.2% | 91,185 | +120.1% | 0.01% | +150.0% |
| Q4 2020 | $145,000 | – | 41,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |